Press Releases
Keep up to date with Isogenica’s latest news on collaborations and press releases.
Isogenica’s
Latest News
PRESS RELEASES
Silent in one assay, potent in another: VHHs unlock a new way to block the cancer resistance target CDK2
Isogenica and Axxam identified VHH antibodies that inhibit CDK2 kinase activity or prevent CDK2/CycE1 complex formation. Their joint case study highlights how complementary functional assays can reveal promising activity that a single assay would miss.
Cerberus Therapeutics Enters into Antibody Discovery Agreement with Isogenica to Advance Immune-Modulating Therapies
Strategic collaboration offering a transformative approach to synthetic VHH and peptide discovery integrating early-stage drug development.
From Hit to Clinic: Isogenica and Charles River Collaborate to Accelerate Next-Generation Peptide and VHH Discovery
Strategic collaboration offering a transformative approach to synthetic VHH and peptide discovery integrating early-stage drug development.